Aequanimitas Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 8,400 shares at $6.03 ($51K) on 2022-12-30, disclosed to the SEC on 2023-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.